STAAR SURGICAL CO — Director's Dealing 2021

Sep 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2021-09-07

Reporting Person: Blickensdoerfer Hans-Martin (Sr. VP, Comm. Ops, China)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-07	Common Stock	S	11522	$157.40	Disposed	77200	Direct
2021-09-07	Common Stock	M	14031	$35.98	Acquired	91231	Direct
2021-09-07	Common Stock	M	15100	$27.53	Acquired	106331	Direct
2021-09-07	Common Stock	S	29131	$157.40	Disposed	77200	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-07	Common Stock Options	$35.98	M	14031	Disposed	2029-03-13	Common Stock (14031)	Direct
2021-09-07	Common Stock Options	$27.53	M	15100	Disposed	2030-03-19	Common Stock (15100)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.40 to $157.45, inclusive.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.40 to $157.46, inclusive.

F3: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/13/2029.

F4: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the next 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.